<!DOCTYPE html>

<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sedative-Hypnotics - Essentials of Medical Pharmacology</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <link rel="stylesheet" href="../styles/main.css">

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>

    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Floating TOC -->

    <nav class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span> Table of Contents
        </div>
        <ul class="floating-toc-list">
            <li><a href="#definitions">Definitions & Overview</a></li>
            <li><a href="#classification">Classification</a></li>
            <li><a href="#barbiturates">Barbiturates</a></li>
            <li><a href="#benzodiazepines">Benzodiazepines</a></li>
            <li><a href="#mechanism">Mechanism: GABA-A Receptor</a></li>
            <li><a href="#z-drugs">Newer Nonbenzodiazepines</a></li>
            <li><a href="#uses">Clinical Uses</a></li>
            <li><a href="#case-study">Problem Directed Study</a></li>
        </ul>
    </nav>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üò¥</span>
                        <span>Topic 30</span>
                    </div>
                    <h1 class="document-title">Sedative-Hypnotics</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Central Nervous System</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>45 min read</span>
                        </div>
                    </div>
                </header>
                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Introduction -->
                    <section class="content-section" id="definitions">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìñ</span>
                                Definitions & Overview
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Sedative-hypnotics are CNS depressants. The distinction between a sedative and a hypnotic
                                is largely dose-dependent.</p>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Sedative</h4>
                                    <p>A drug that reduces excitement, calms the patient (without inducing sleep), and
                                        decreases motor activity and mental acuity. Key feature:
                                        <strong>Anxiolysis</strong>.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Hypnotic</h4>
                                    <p>A drug that produces sleep resembling natural sleep. Higher doses of sedatives
                                        act as hypnotics.</p>
                                </div>
                            </div>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Dose-Response Relationship</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>Barbiturates (Steep Curve):</strong> Linear progression from Sedation
                                        $\rightarrow$ Sleep $\rightarrow$ Anesthesia $\rightarrow$ Coma $\rightarrow$
                                        Death. Low safety margin.</p>
                                    <p><strong>Benzodiazepines (Flat Curve):</strong> Ceiling effect. Sedation
                                        $\rightarrow$ Sleep $\rightarrow$ Hypnosis. Difficult to achieve anesthesia or
                                        fatal coma with oral doses alone.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 2: Classification -->
                    <section class="content-section" id="classification">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìä</span>
                                Classification
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>1. Benzodiazepines (BZDs)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Short acting:</strong> Triazolam, Midazolam (t¬Ω 2-3 hrs).
                                </li>
                                <li class="list-item"><strong>Intermediate acting:</strong> Alprazolam, Temazepam,
                                    Lorazepam, Oxazepam.</li>
                                <li class="list-item"><strong>Long acting:</strong> Diazepam, Flurazepam, Nitrazepam.
                                </li>
                            </ul>

                            <h3>2. Barbiturates</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Long acting:</strong> Phenobarbitone.</li>
                                <li class="list-item"><strong>Short acting:</strong> Pentobarbitone, Secobarbitone.</li>
                                <li class="list-item"><strong>Ultra-short acting:</strong> Thiopentone (IV anaesthetic).
                                </li>
                            </ul>

                            <h3>3. Newer Nonbenzodiazepines (Z-drugs)</h3>
                            <p>Zolpidem, Zopiclone, Zaleplon, Eszopiclone.</p>

                            <h3>4. Melatonin Receptor Agonists</h3>
                            <p>Ramelteon.</p>
                        </div>
                    </section>

                    <!-- Section 3: Barbiturates -->
                    <section class="content-section" id="barbiturates">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ò†Ô∏è</span>
                                Barbiturates
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>General depressants of all excitable cells. Popularity has declined due to low
                                therapeutic index, high abuse potential, and interactions.</p>

                            <h3>Mechanism</h3>
                            <p>Bind to specific site on <strong>GABA<sub>A</sub></strong> receptor. Potentiate GABA
                                action by increasing the <strong>Duration</strong> of Cl<sup>-</sup> channel opening
                                ("Barbiturate Duration"). At high concentrations, they can directly open the channel
                                (GABA-mimetic).</p>

                            <h3>Adverse Effects</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Hangover:</strong> Residual depression, drowsiness next
                                    morning.</li>
                                <li class="list-item"><strong>Paradoxical excitement:</strong> In children and elderly.
                                </li>
                                <li class="list-item"><strong>Hyperalgesia:</strong> Increased sensitivity to pain in
                                    subanesthetic doses.</li>
                                <li class="list-item"><strong>Drug Interactions:</strong> Potent <strong>Microsomal
                                        Enzyme Inducers</strong> (CYP450). Reduces efficacy of Warfarin, Steroids, OCPs.
                                </li>
                                <li class="list-item"><strong>Precipitation of Porphyria:</strong> Induce ALA synthase.
                                </li>
                            </ul>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Acute Barbiturate Poisoning</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>Signs:</strong> Coma, respiratory depression, hypotension, cutaneous
                                        blisters (Barbiturate burns), renal failure.</p>
                                    <p><strong>Treatment:</strong> No specific antidote. Supportive care (Airway,
                                        Breathing, Circulation). <strong>Alkaline Diuresis</strong> (Sodium bicarbonate)
                                        promotes excretion of long-acting barbiturates (Phenobarbitone) because they are
                                        weak acids.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 4: Benzodiazepines -->
                    <section class="content-section" id="benzodiazepines">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Benzodiazepines (BZDs)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Replaced barbiturates as hypnotics/sedatives. High therapeutic index. No enzyme
                                induction.</p>

                            <h3>Mechanism</h3>
                            <p>Bind to specific BZD site on the <strong>GABA<sub>A</sub></strong> receptor complex.
                                Potentiate GABA binding and increase the <strong>Frequency</strong> of Cl<sup>-</sup>
                                channel opening ("Benzodiazepine Frequency"). Do not have direct GABA-mimetic action.
                            </p>

                            <h3>Actions</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Sedation/Hypnosis:</strong> Decrease sleep latency,
                                    increase sleep duration. Alter sleep architecture (Stage 2 increased, REM and Slow
                                    Wave Sleep decreased).</li>
                                <li class="list-item"><strong>Anxiolytic:</strong> Selective action on limbic system.
                                </li>
                                <li class="list-item"><strong>Muscle Relaxant:</strong> Central action.</li>
                                <li class="list-item"><strong>Anticonvulsant:</strong> Diazepam/Lorazepam IV for status
                                    epilepticus.</li>
                                <li class="list-item"><strong>Anterograde Amnesia:</strong> Useful for minor
                                    surgeries/endoscopy.</li>
                            </ul>

                            <h3>Pharmacokinetics</h3>
                            <p>Lipid soluble. Metabolized in liver. Many have active metabolites (e.g., Diazepam
                                $\rightarrow$ Desmethyldiazepam $\rightarrow$ Oxazepam), leading to cumulative effects.
                            </p>

                            <div class="callout callout--success">
                                <div class="callout-header">
                                    <span class="callout-icon">üõ°Ô∏è</span>
                                    <h4 class="callout-title">Advantages over Barbiturates</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li>High safety margin (difficult to commit suicide).</li>
                                        <li>Low abuse potential.</li>
                                        <li>No enzyme induction (fewer interactions).</li>
                                        <li>Less effect on REM sleep (less rebound dreaming).</li>
                                        <li><strong>Specific Antagonist Available: Flumazenil</strong>.</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 5: GABA Receptor -->
                    <section class="content-section" id="mechanism">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                GABA<sub>A</sub> Receptor Complex
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>A pentameric ligand-gated Chloride channel. Major inhibitory receptor in CNS.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Binding Site</th>
                                            <th>Ligand</th>
                                            <th>Effect</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>GABA Site</strong></td>
                                            <td>GABA, Muscimol</td>
                                            <td>Opens Cl<sup>-</sup> channel (Hyperpolarization).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Barbiturate Site</strong></td>
                                            <td>Barbiturates</td>
                                            <td>Prolongs opening duration.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Benzodiazepine Site</strong></td>
                                            <td>BZDs (Agonist)</td>
                                            <td>Increases opening frequency.</td>
                                        </tr>
                                        <tr>
                                            <td></td>
                                            <td>Flumazenil (Antagonist)</td>
                                            <td>Blocks BZDs and Z-drugs.</td>
                                        </tr>
                                        <tr>
                                            <td></td>
                                            <td>$\beta$-Carbolines (Inverse Agonist)</td>
                                            <td>Anxiety, convulsions (closes channel).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Channel Pore</strong></td>
                                            <td>Picrotoxin</td>
                                            <td>Blocks channel (Convulsant).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 6: Z-Drugs -->
                    <section class="content-section" id="z-drugs">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üÜï</span>
                                Newer Nonbenzodiazepine Hypnotics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Zolpidem, Zaleplon, Zopiclone.</strong></p>
                            <p>Chemically distinct from BZDs but act on the same BZD receptor site. They are selective
                                for the <strong>$\alpha$1 subunit</strong> of the GABA<sub>A</sub> receptor.</p>

                            <h3>Advantages</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Pure Hypnotic:</strong> Minimal anxiolytic, muscle
                                    relaxant, or anticonvulsant effects.</li>
                                <li class="list-item"><strong>Sleep Architecture:</strong> Minimal effect on sleep
                                    stages (REM/SWS maintained).</li>
                                <li class="list-item"><strong>Pharmacokinetics:</strong> Rapid onset, short duration.
                                    Minimal hangover/daytime sedation.</li>
                                <li class="list-item"><strong>Tolerance/Dependence:</strong> Very low. Minimal rebound
                                    insomnia.</li>
                                <li class="list-item"><strong>Reversal:</strong> Antagonized by Flumazenil.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 7: Uses -->
                    <section class="content-section" id="uses">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Clinical Uses
                            </h2>
                        </div>

                        <div class="content-card">
                            <ol class="enhanced-list">
                                <li class="list-item"><strong>Insomnia:</strong>
                                    <ul>
                                        <li>Sleep onset difficulty: Zolpidem, Triazolam.</li>
                                        <li>Frequent waking/early morning waking: Temazepam, Nitrazepam
                                            (intermediate/long acting).</li>
                                        <li>Preferred agents: Z-drugs (Zolpidem) due to less tolerance/hangover.</li>
                                    </ul>
                                </li>
                                <li class="list-item"><strong>Anxiety Disorders:</strong> Diazepam, Alprazolam,
                                    Lorazepam. (For acute management; SSRIs preferred for long term).</li>
                                <li class="list-item"><strong>Anticonvulsant:</strong>
                                    <ul>
                                        <li>Status Epilepticus: Lorazepam/Diazepam IV.</li>
                                        <li>Maintenance: Phenobarbitone, Clonazepam.</li>
                                    </ul>
                                </li>
                                <li class="list-item"><strong>Preanesthetic Medication:</strong> Midazolam (sedation +
                                    amnesia).</li>
                                <li class="list-item"><strong>Muscle Relaxation:</strong> Diazepam (tetanus, spasms).
                                </li>
                                <li class="list-item"><strong>Alcohol Withdrawal:</strong> Diazepam/Chlordiazepoxide
                                    (cross-dependence prevents withdrawal seizures).</li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 8: Case Study -->
                    <section class="content-section" id="case-study">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§î</span>
                                Problem Directed Study
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 29.1</h4>
                                </div>
                                <div class="callout-content">
                                    <p>A 70-year-old man complains of insomnia (difficulty staying asleep). He was
                                        prescribed Diazepam 10 mg at bedtime. He now complains of daytime drowsiness,
                                        unsteadiness, and falls.</p>
                                    <p><strong>(a) Reason for Symptoms:</strong> Diazepam is a long-acting BZD with
                                        active metabolites. In the elderly, hepatic metabolism is reduced, leading to
                                        accumulation. The residual sedation ("hangover") causes drowsiness. BZDs also
                                        cause muscle relaxation, which in an elderly patient leads to ataxia and falls
                                        (hip fracture risk).</p>
                                    <p><strong>(b) Better Choice:</strong> A short-acting nonbenzodiazepine like
                                        <strong>Zolpidem</strong> or <strong>Zaleplon</strong> would be better. They
                                        have short half-lives (no hangover), preserve sleep architecture, and have
                                        minimal muscle relaxant effects (lower risk of falls). If a BZD must be used,
                                        <strong>Temazepam</strong> or <strong>Oxazepam</strong> (intermediate acting, no
                                        active metabolites, glucuronidation pathway preserved in elderly) are preferred
                                        over Diazepam.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-29-alcohols.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Ethyl & Methyl Alcohols</div>
                        </a>

                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>30</span>
                                <span class="progress-separator">/</span>
                                <span>72</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 41.6%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>

                        <a href="topic-31-antiepileptics.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Antiepileptic Drugs</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="../js/theme.js"></script>

    <script src="../js/navigation.js"></script>

    <script src="../js/interactions.js"></script>

</body>

</html>